confounding factors

Related by string. Confounding Factor * confounded . confounds . Confounding . Confounded . confounder : residual confounding . confounded skeptics . confounds conventional wisdom . potentially confounding variables . confounding variables / factoring . factored . Factors . Factor : CERTAIN MARKET FACTORS SUCH . Risk Factors section . heading Risk Factors . Item 1A Risk Factors * *

Related by context. All words. (Click for frequent words.) 79 confounders 79 confounding variables 74 potential confounders 70 covariates 63 residual confounding 63 sociodemographic factors 61 covariate 61 comorbidities 61 unmeasured confounders 60 confounder 60 unmeasured factors 60 sociodemographic 59 potential confounding variables 58 potentially confounding variables 58 comorbid conditions 58 sociodemographic variables 58 socioeconomic status 57 demographic variables 57 prognostic factors 57 multivariate logistic regression 57 variables 57 multivariate analyzes 56 comorbidity 56 sociodemographic characteristics 55 subgroup analyzes 55 multivariate analysis 55 logistic regression analysis 55 conditional logistic regression 54 logistic regression model 54 macrovascular disease 54 lipid abnormalities 54 antenatal depression 54 Observational studies 54 APOE genotype 54 multivariable analysis 54 univariate 54 Logistic regression 53 multivariate adjustment 53 stepwise logistic regression 53 causal pathway 53 regression analyzes 53 subclinical hyperthyroidism 53 orofacial clefts 53 logistic regression models 53 logistic regression analyzes 53 multiple logistic regression 53 fetal malformations 52 genetic polymorphisms 52 NNRTI resistance 52 odds ratios ORs 52 univariate analyzes 52 obstetric complications 52 antihypertensive medications 52 MDRD equation 52 nongenetic 52 metabolic abnormalities 52 unmeasured confounding 52 bivariate analyzes 52 inflammatory biomarkers 51 morbidities 51 meta regression 51 sociodemographics 51 Subgroup analyzes 51 hypoglycemic episodes 51 antihypertensive medication 51 QTc prolongation 51 psychiatric comorbidities 51 clinically insignificant 51 neurocognitive impairment 51 antidiabetic medications 51 ascertainment bias 51 socioeconomic deprivation 51 Univariate 51 colorectal neoplasia 51 folate intake 51 psychosocial variables 51 hypoglycemic events 51 modifiable risk 51 familial clustering 51 TEAEs 51 metabolic parameters 51 newer atypical antipsychotics 51 neurodevelopmental outcome 50 cystatin C 50 tHcy 50 carotid atherosclerosis 50 hippocampal volume 50 lignan intake 50 meta analyzes 50 Logistic regression analysis 50 psychiatric comorbidity 50 SRBD 50 observational studies 50 HRQL 50 atopy 50 subclinical hypothyroidism 50 cotinine levels 50 explanatory variables 50 socioeconomic variables 50 cephalic presentation 50 Multivariate analysis 50 impaired insulin secretion 50 fasting glucose levels 50 co morbidities 50 shorter telomere length 50 prenatal exposures 50 biochemical abnormalities 50 glomerular filtration rate 50 thiazide diuretics 50 non pharmacological interventions 50 Baseline characteristics 50 multivariate Cox 50 CVD mortality 50 nongenetic factors 50 flavonoid intake 50 thyroid hormone levels 50 predisposing factors 50 potentially modifiable 50 acrylamide intake 50 serum cholesterol 50 body fatness 49 advanced adenomas 49 estrogen metabolism 49 comorbid illnesses 49 remnant lipoproteins 49 paternal discrepancy 49 gestational diabetes mellitus 49 etiologic 49 obstructive coronary artery 49 migraine triggers 49 symptomatic intracerebral hemorrhage 49 epidemiologic studies 49 estimated GFR 49 familial predisposition 49 nonfatal MI 49 etiological factors 49 slow metabolizers 49 elevated CRP 49 metabolite concentrations 49 endometrial hyperplasia 49 poor metabolizers 49 glucose abnormalities 49 Leitzmann 49 hereditary predisposition 49 subclinical atherosclerosis 49 adenomatous polyps 49 probiotic supplementation 49 nonsignificant 49 hyperbilirubinemia 49 mammographic density 49 alexithymia 49 plasma lipids 49 surrogate markers 49 colorectal adenoma 49 comorbid depression 49 concomitant medications 49 FDG PET scans 49 allele frequencies 49 subclinical cardiovascular disease 49 systolic BP 49 genetic susceptibility 49 neurodevelopmental outcomes 49 congenital malformations 49 β blockers 49 Univariate analysis 49 dietary intakes 49 untreated hypothyroidism 49 renal dysfunction 49 Genetic variants 49 chromosomal alterations 49 methodological limitations 49 logistic regression 49 tumor histology 49 congenital anomalies 49 Socioeconomic status 49 cryptorchidism 49 antihypertensive drugs 49 BMI z 49 psychotic illnesses 49 impaired glucose metabolism 49 dietary antioxidants 49 lipid levels 49 utero exposure 49 loop diuretics 49 dietary patterns 49 gene polymorphisms 49 correlational 49 Multivariate analyzes 49 reflux symptoms 48 univariate analysis 48 thromboembolism 48 testicular tumors 48 gallstone disease 48 inflammatory markers 48 CHD mortality 48 MetS 48 statistically significant differences 48 lipid parameters 48 thyrotropin levels 48 extrapyramidal symptoms 48 biologically plausible 48 postmenopausal hormone 48 Multiple linear regression 48 multivariable adjusted 48 polygenic 48 polyp recurrence 48 perinatal outcomes 48 asthma exacerbations 48 sulphonylureas 48 neuropsychiatric symptoms 48 Genetic predisposition 48 depressive symptoms 48 parous women 48 cardiovascular mortality 48 premenopausal 48 SHBG levels 48 prognostic variables 48 generalizability 48 serum lipids 48 clinically meaningful differences 48 perioperative complications 48 dysglycemia 48 exploratory endpoints 48 adiposity 48 abnormal lipid levels 48 MMSE score 48 inverse association 48 habitual snoring 48 glycated hemoglobin levels 48 Multiple logistic regression 48 neurocognitive function 48 FeNO 48 BRCA1 mutations 48 Meta analyzes 48 obesity sedentary lifestyle 48 vitamin D inadequacy 48 HRQOL 48 neurocognitive functioning 48 hematopoietic cancers 48 familial AF 48 BMD measurements 48 coronary calcification 48 Efficacy endpoints 48 lipid lowering agents 48 MDRD 48 sideeffects 48 neuropsychological deficits 48 gastrointestinal GI bleeding 48 susceptibility genes 48 chromosomal disorders 48 warfarin dosage 48 CYP#D# genotype 48 teratogenic 48 perinatal complications 48 Singh Manoux 48 plasma homocysteine 48 intima media thickness 48 magnesium intake 47 noncancer 47 Bonferroni correction 47 preterm deliveries 47 dietary intake 47 randomized controlled trials RCTs 47 lipid lowering drugs 47 artery calcification 47 genetic determinants 47 serum calcium 47 RCTs 47 hydroxyvitamin D levels 47 Depressive symptoms 47 metabolic disturbances 47 lipid lowering therapies 47 lipid lowering medications 47 nocturnal hypoglycemia 47 autistic traits 47 strongest predictors 47 transferrin saturation 47 abnormalities 47 bronchopulmonary dysplasia 47 pharmacologic treatments 47 LV dysfunction 47 triacylglycerol concentrations 47 factors 47 folate deficiency 47 Longitudinal studies 47 CrCl 47 folate supplementation 47 diagnose clinically 47 tamoxifen metabolism 47 menarche 47 hypertension diabetes mellitus 47 occupational exposures 47 SGAs 47 colorectal adenomas 47 hypoxemia 47 premenopausal breast cancer 47 predisposing factor 47 sedentary behaviors 47 ovarian hormones 47 serum vitamin D 47 GBA mutations 47 adiponectin levels 47 underlying pathophysiology 47 serum creatinine levels 47 methodological shortcomings 47 demographic characteristics 47 SIDS infants 47 MGUS 47 ATACAND 47 albuminuria 47 postoperative mortality 47 androgen depletion 47 autonomic dysfunction 47 bile acid metabolism 47 nutrient intakes 47 liver transplant recipients 47 atopic 47 airway responsiveness 47 stratifying patients 47 inherited predisposition 47 PSA velocity 47 noncardiovascular 47 cardioembolic stroke 47 Reynolds Risk Score 47 serum cotinine levels 47 phthalate exposure 47 adrenal suppression 47 Charlson comorbidity index 47 VADT 47 TT genotype 47 index BMI 47 nonrandomized 47 dietary interventions 47 neurologic abnormalities 47 multivariable Cox 47 epigenetic changes 47 elevated LDH 47 Comorbid 47 cerebral microbleeds 47 somatic symptoms 47 commonly prescribed antidepressants 47 chlorthalidone 47 dietary calcium intake 47 virologically 47 microbleeds 47 dietary folate intake 47 abnormal glucose tolerance 47 fructose intake 47 postoperative AF 47 multivariable analyzes 47 atypical antipsychotic medications 47 lifetime abstainers 47 psychiatric morbidity 47 psychosocial functioning 47 methodological flaws 46 TNF blocker therapy 46 persistent pulmonary hypertension 46 serum biomarkers 46 comorbid disorders 46 macrovascular events 46 externalizing behaviors 46 nulliparous women 46 Poisson regression 46 neurological abnormalities 46 non aspirin NSAIDs 46 hypercholesterolemia 46 serum GGT 46 serum concentrations 46 nomograms 46 genetic susceptibilities 46 telomere lengths 46 depressive symptomatology 46 serum BDNF 46 genetic polymorphism 46 antioxidant supplementation 46 obstructive CAD 46 carotid IMT 46 de ath 46 Glomerular filtration rate 46 rs# [001] 46 generalized estimating 46 thrombotic events 46 environmental toxicants 46 pharmacodynamic parameters 46 cardio respiratory fitness 46 MYH9 46 confidence intervals CIs 46 intact parathyroid hormone 46 Comorbidities 46 nicotine metabolite 46 physiologic parameters 46 Hertz Picciotto 46 pharmacological approaches 46 homocysteine concentrations 46 fasting insulin 46 Schaffir 46 salivary cortisol 46 antidiabetic medication 46 obstructive lung 46 Pischon 46 Calcium intake 46 postsurgical complications 46 urinary calcium 46 PON1 46 highly heritable 46 teratogens 46 multifactorial 46 NAFLD 46 parkinsonism 46 developmental abnormalities 46 nondemented 46 retrospective cohort 46 endogenous hormones 46 PM#.# exposure 46 HRQoL 46 statistically significant correlations 46 beta carotene supplementation 46 methylation patterns 46 urate levels 46 neurodevelopmental impairment 46 nonpharmacologic 46 multivariate regression 46 Kozyrskyj 46 coronary stenosis 46 familial aggregation 46 abdominal adiposity 46 vertebral fracture 46 noncardiovascular mortality 46 hormonal abnormalities 46 SE alleles 46 irregular menses 46 euthymic patients 46 carotid plaque 46 hypercholesterolaemia 46 periodontal infections 46 KIF6 carriers 46 CLBP 46 HbA1c levels 46 pesticide exposures 46 antiplatelet therapies 46 deleterious mutations 46 hypersomnia 46 proportional hazards 46 recurrent miscarriage 46 statistically significant 46 predictor variables 46 choline intake 46 aldosterone antagonist 46 androgen excess 46 prognostic indicators 46 left ventricular dysfunction 46 albumin excretion rate 46 low birthweight 46 chromium picolinate supplementation 46 HbA1C levels 46 gene loci 46 meta analytic 46 QT interval prolongation 46 serum markers 46 overt hypothyroidism 46 plasma pharmacokinetics 46 Kaplan Meier curves 46 Complication rates 46 socio demographic 46 sonographic diagnosis 46 ELBW infants 46 differential gene expression 46 nonhematologic adverse reactions 46 Prehypertension 46 causal pathways 46 Cockcroft Gault 46 microdeletion 46 myocardial dysfunction 46 tibolone 46 tic severity 46 anovulatory infertility 46 adjuvant therapies 46 creatinine levels 46 abstinent alcoholics 46 Cochrane reviewers 46 tertile 46 baseline HbA1c 46 prenatal exposure 46 non selective NSAIDs 46 ethosuximide 46 diagnosing ADHD 46 serum potassium levels 46 anthropometric measures 46 undergone hysterectomy 46 Hb A1C 46 obesity insulin resistance 46 cerebral infarction 46 colorectal polyps 46 genotypic resistance 46 hormone receptor status 45 lowering systolic blood 45 Lp PLA2 45 depressive symptom 45 polycystic ovary syndrome 45 adverse perinatal 45 nondepressed 45 biochemical markers 45 spirometric 45 methodologic 45 birthweight 45 triglyceride lowering 45 dietary fiber intake 45 SNP rs# [002] 45 APOE ε4 45 Descriptive statistics 45 hypovitaminosis D 45 serum IGF 45 lowering homocysteine 45 ischemic cardiovascular 45 longitudinal studies 45 decompensated cirrhosis 45 tertiles 45 meta analysis 45 plasma lipid 45 androgen suppression 45 bivariate 45 multiple linear regression 45 Dr. Stefanos Kales 45 preterm delivery 45 Personality traits 45 chromosomal rearrangement 45 dysfunctional voiding 45 borderline statistical significance 45 bivariate analysis 45 coinfection 45 subclinical inflammation 45 K ras mutations 45 oophorectomy 45 CTEPH 45 developmental trajectories 45 microalbuminuria 45 aneuploidy 45 postoperative complications 45 Cognitive impairment 45 thromboembolic events 45 prospectively defined 45 randomized trials 45 predictors 45 Waist circumference 45 HbA 1c 45 Cotinine 45 cardioprotective effect 45 epidemiological studies 45 psychiatric disorders 45 recurrent atrial fibrillation 45 HbA 1c levels 45 susceptibility loci 45 premorbid 45 adrenal function 45 postmenopausal hormones 45 author Katherine Flegal 45 clinico pathological 45 visceral adiposity 45 highest quintile 45 % CI #.#-#.# [006] 45 clefting 45 developmental neurotoxicity 45 Secondhand smoke exposure 45 HIV HCV coinfected 45 acetabular dysplasia 45 adenomas 45 endometriosis ovarian cysts 45 CYP #A# 45 lipid concentrations 45 confidence interval CI 45 genetic locus 45 cortical activation 45 RBP4 levels 45 artifactual 45 dietary acrylamide 45 polytherapy 45 microvascular disease 45 normotensive 45 MMSE scores 45 oral cleft 45 coronary artery calcification 45 gestational age 45 atypical hyperplasia 45 spontaneous preterm delivery 45 atherogenic dyslipidemia 45 prognostic markers 45 BRCA1 mutation carriers 45 ratio WHR 45 nodal metastases 45 modifiable lifestyle 45 carotid plaques 45 histologies 45 pretest probability 45 renal function 45 internalizing behaviors 45 QT prolongation 45 heritability 45 paricalcitol 45 NHANES 45 cardiometabolic risk 45 neurodevelopmental disorders 45 timepoints 45 allergic sensitization 45 VLBW infants 45 dyslipidemia hypertension 45 congenital abnormalities 45 psychiatric diagnoses 45 advanced adenoma 45 #q# deletion 45 macrovascular complications 45 perinatal mortality 45 IUGR 45 tumor subtypes 45 cardiovascular disease hypertension 45 thyroid stimulating hormone 45 monozygotic twins 45 testosterone supplementation 45 macrovascular 45 use disorders AUDs 45 insulin glargine 45 Multivariable logistic regression 45 CYP#D# inhibitor 45 CYP#C# genotype 45 definite stent thrombosis 45 hsCRP levels 45 apolipoprotein B 45 angiotensin II receptor blockers 45 serum lipid levels 45 density lipoprotein cholesterol 45 phthalate metabolites 45 pharmacological interventions 45 pg ml 45 IGFBP 45 BLLs 45 folic acid supplement 45 RLS symptoms 45 serum selenium 45 triglyceride concentration 45 Telomere length 45 beta blocker therapy 45 reach statistical significance 45 basal cell nevus syndrome 45 neurocognitive deficits 45 statistically nonsignificant 45 oral antidiabetic agents 45 KRAS status 45 contrast induced nephropathy 45 T2D 45 perimenopausal women 45 glycemia 45 psychosocial stressors 45 CARDIA study 45 serum leptin 45 albumin excretion 45 prognostic indicator 45 physiologic responses 45 EGFR mutation status 45 postoperative complication 45 multi factorial disease 45 prolactin levels 45 epigenetic mechanisms 45 chronicity 45 elevated LDL cholesterol 45 assortative mating 45 serum PTH 44 bronchopulmonary dysplasia BPD 44 folic acid supplementation 44 diabetes hypertension hyperlipidemia 44 underdiagnosis 44 prenatal testosterone 44 plasma homocysteine levels 44 vitamin D insufficiency 44 serum folate 44 dietary calcium 44 myocardial viability 44 methodological weaknesses 44 pharmacokinetic interactions 44 elevated depressive symptoms 44 pharmacokinetic interaction 44 genetic loci 44 overt nephropathy 44 metabolizer 44 MTHFD1L gene 44 NHANES III 44 Cystatin C 44 nondiabetics 44 blood lipids 44 prostate carcinogenesis 44 calcium supplementation 44 hyperlipidemia hypertension 44 behavioral disinhibition 44 recurrent venous thromboembolism 44 left ventricular hypertrophy 44 VTEs 44 gene variants 44 NIHSS score 44 transaminase elevations 44 nonvertebral fractures 44 creatinine clearance 44 strongest predictor 44 Sociodemographic 44 oxygen saturations 44 primary aldosteronism 44 genotypic 44 airway hyperresponsiveness 44 2D 4D ratio 44 PTEN mutations 44 susceptibility locus 44 valproate 44 serum glucose 44 LQTS 44 thrombophilia 44 shorter telomeres 44 carotid stenosis 44 waist circumference WC 44 recurrent UTI 44 abnormal lipid 44 RBP4 44 endometrial thickness 44 genetic variants 44 glucose intolerance 44 serum creatinine 44 onset sepsis 44 BMI waist circumference 44 pulmonary exacerbations 44 methodological differences 44 behavioral disturbances 44 thimerosal exposure 44 Primary endpoints 44 etiologic factors 44 serum uric acid 44 nonfasting triglyceride levels 44 quartiles 44 epigenetic markers 44 metabolic dysfunction 44 etiologies 44 systolic blood pressure 44 warfarin dose 44 serum estradiol 44 nonvertebral fracture 44 serum lipid 44 chorioamnionitis 44 LDL HDL 44 stressors 44 atherosclerotic vascular disease 44 hyperkalemia 44 telomere length 44 structural abnormalities 44 placental hormones 44 serotonin deficiency 44 glycosylated hemoglobin HbA1c 44 histologic subtype 44 ConclusionThis 44 affective psychoses 44 Torsades de Pointes 44 hemorrhagic complications 44 fasting triglyceride levels 44 Epidemiologic studies 44 cognitive deficits 44 macrosomia 44 mcg dl 44 ABCB1 44 thrombotic complications 44 plasma selenium 44 neurocognitive 44 antipsychotic induced 44 serum potassium 44 #q#.# deletion syndrome 44 lipid profiles 44 Postnatal depression 44 poststroke depression 44 multivariable 44 Kaplan Meier analysis 44 preeclamptic 44 virologic failure 44 Exclusion criteria 44 irregular menstrual cycles 44 prostate cancer CaP 44 metabolic alterations 44 Linear regression 44 atopic diseases 44 thiopurine 44 #OHD 44 multivariable adjustment 44 Boden Albala 44 HbA 1C 44 gestational hypertension 44 visceral fat accumulation 44 noncardiac chest pain 44 exhaled nitric oxide 44 CYP#D# 44 Maternal obesity 44 pathophysiologic mechanisms 44 confidence interval #.#-#.# 44 genetic variations 44 overactive bladder symptoms 44 HOMA IR 44 Triglyceride levels 44 multivariate regression analysis 44 secondary efficacy endpoints 44 Kaplan Meier curve 44 neurosensory 44 G6PD deficiency 44 cholestasis 44 monozygotic 44 aspirin NSAID 44 Complications Trial 44 caffeine intake 44 Logistic regression models 44 rs# [004] 44 advanced neoplasia 44 baseline LDH 44 thromboembolic disease 44 adiponectin concentrations 44 rs# [003] 44 precursor lesions 44 postmenopausal breast cancer 44 T2DM 44 monoclonal gammopathy 44 depression suicidal ideation 44 DNA methylation patterns 44 statistically significant correlation 44 histologic subtypes 44 HLA DRB1 44 ALT flares 44 asthma exacerbation 44 irregular menstrual periods 44 Heritability 44 beta carotene supplements 44 type2 diabetes 44 lipid lowering therapy 44 phenotypic variability 44 metformin monotherapy 44 Heavy snorers 44 neurologic complications 44 CYP#D# gene 44 toxicities 44 eGFR 44 albumin creatinine ratio 44 cardiopulmonary diseases 44 intima media thickness IMT 44 allelic variation 44 lethal arrhythmias 44 laboratory abnormalities 44 variance ANOVA 44 oxygen desaturation 44 myocardial infarction stroke 44 noncardiac 44 triglyceride levels 44 nonfasting 44 HPA axis 44 Genetic variations 43 prospective cohort 43 calcium intake 43 DHEA supplementation 43 INTERHEART study 43 lipoprotein 43 pairwise comparisons 43 5 HTTLPR genotype 43 airflow obstruction 43 inherited mutations 43 GSTM1 43 proteinuria 43 interindividual variability 43 hypertensives 43 echocardiographic parameters 43 biological plausibility 43 estimated glomerular filtration 43 dietary folate 43 socioeconomics 43 actigraphy 43 genes predisposing 43 somatoform disorders 43 affective disorders 43 interobserver reliability 43 cardiac malformations 43 antihypertensive therapy 43 amenorrhea 43 schizotypal traits 43 hemoglobin A1c HbA1c 43 serum cotinine 43 atherothrombotic 43 plasma glucose 43 pre menopausal 43 parous 43 HDL particle 43 Brenda Eskenazi 43 lowest tertile 43 comorbid 43 #,# DCB 43 prognostic biomarker 43 APOE e4 43 thromboembolic complications 43 laterality 43 PTEN protein 43 pre eclamptic 43 serum PSA 43 physico chemical properties 43 proband 43 tamsulosin 43 hemodynamic parameters 43 karyotypes 43 Framingham Risk Score 43 multivariable logistic regression 43 prognostic marker 43 polymorphism 43 overdiagnosis 43 genetic variants associated 43 ADHD symptoms 43 hsCRP 43 alcoholic fatty liver 43 ethnicity socioeconomic status 43 body habitus 43 prevalences 43 atypical neuroleptics 43 plasma triglycerides 43 regression coefficient 43 polycystic ovary syndrome PCOS 43 obstetric interventions 43 insulin resistance syndrome 43 PBDE exposure 43 Goldbourt 43 hormone therapy estrogen 43 randomized controlled trials 43 improves insulin sensitivity 43 diastolic pressures 43 coronary artery atherosclerosis 43 ECG abnormalities 43 neurodevelopmental 43 Secondary endpoints 43 lowering homocysteine levels 43 probands 43 pharmacodynamic markers 43 AMOR IPAT 43 chromosomal regions 43 ovarian dysfunction 43 nonexposed 43 angiotensin converting enzyme inhibitors 43 nondiabetic patients 43 CNVs 43 convergent validity 43 lymph node involvement 43 impaired fasting glucose 43 lobular breast cancer 43 genetic predisposition 43 exposed prenatally 43 Soy isoflavones 43 hydroxyvitamin D 43 NNT = 43 fasting serum 43 serum retinol 43 neurodevelopment 43 statistical correlations 43 eplerenone 43 untreated celiac disease 43 metabolic dysregulation 43 pressor response 43 urolithiasis 43 MELD scores 43 renal toxicity 43 arterial thromboembolic events 43 GI bleeding 43 neonatal encephalopathy 43 hs CRP 43 parasomnias 43 subanalysis 43 mtDNA mutations 43 psychopathological symptoms 43 imply causality 43 enterotypes 43 Variables 43 cardiovascular comorbidities 43 daytime sleepiness 43 GABRA2 43 Glucocorticoids 43 platelet reactivity 43 Erythropoietic therapies may 43 colorectal cancer incidence 43 thyroxine 43 dietary sodium 43 malignant polyps 43 pleiotropic effects 43 oestrogens 43 hydrops 43 chromosomal defects 43 gonadal hormones 43 genotypes 43 limiting generalizability 43 elevated triglyceride levels 43 depressive disorders 43 mitochondrial mutations 43 narcolepsy cataplexy 43 endometrial carcinoma 43 EEG abnormalities 43 macronutrient intake 43 nondrinkers 43 thromboembolic 43 #q# deletion syndrome 43 Michele Heisler

Back to home page